- Europeans spend an average of almost 2 hours a day on the move
- 65% use their car to get to their place of work or study: it is the most common mode of transport for all compulsory daily journeys
- 58% of Europeans are dissatisfied with the fluidity of traffic during the rush hour
- A majority of Europeans consider public investments in transport infrastructures insufficient, in particular in terms of intermodality (61%)
- 66% of Europeans would be willing to use their car less often if the necessary investments were made
- 77% believe that future innovations in the field of mobility will have a positive impact on their daily life
A Way to Get Away
Taking vacation is a way to get away for a few days from the fast-paced modern world. But do we take all vacation days available to us? Do we fully disconnect when we are away? A new Ipsos Global @dvisor poll reveals opinions of citizens in 27 countries around the world about taking time off.
2018 Summer Holiday Plans Among Europeans, Americans and Asians
Europ Assistance releases its 18th annual Barometer on Summer holidays, focusing on Europe's, America's, and the first time Asia's holidays plans. In 2018, summer holiday plans are consolidating in all countries with a stable budget in Europe and the United States while increasing in Brazil. Millennials are disrupting traditional practices giving new strength to alternative lodging and online reviews. Social media are becoming a holidays must-have for Asia, the United States and Brazil while Europeans disconnect more easily.
[WEBINAR] Messaging & Motivation: Engaging Participants in Healthcare Research
August 27 - One of the biggest challenges researchers face is recruiting and retaining participants, especially for longitudinal studies or intense clinical trials. Join us for a complimentary webinar to learn innovative ways to enhance recruitment, and maintain participant engagement.
[EVENT] International Conference on Pharmacoepidemiology & Therapeutic Risk Management
August 22-26, Ipsos Healthcare’s Global Evidence, Value and Access (GEVA) team will be exhibiting at the 34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE) being held in Prague, CZ.